TY - JOUR AU - Favus, M. J. PY - 2010 DA - 2010// TI - Bisphosphonates for osteoporosis JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMct1004903 DO - 10.1056/NEJMct1004903 ID - Favus2010 ER - TY - JOUR AU - Fung, P. L. PY - 2015 DA - 2015// TI - Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw JO - Oral Maxillofac Surg Clin N Am VL - 27 UR - https://doi.org/10.1016/j.coms.2015.06.005 DO - 10.1016/j.coms.2015.06.005 ID - Fung2015 ER - TY - JOUR AU - Wysowski, D. K. AU - Greene, P. PY - 2015 DA - 2015// TI - Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002–2012 JO - Bone VL - 57 UR - https://doi.org/10.1016/j.bone.2013.09.008 DO - 10.1016/j.bone.2013.09.008 ID - Wysowski2015 ER - TY - JOUR AU - Woo, S. -. B. AU - Hellstein, J. W. AU - Kalmar, J. R. PY - 2006 DA - 2006// TI - Systematic review: bisphosphonates and osteonecrosis of the jaws JO - Ann Intern Med VL - 144 UR - https://doi.org/10.7326/0003-4819-144-10-200605160-00009 DO - 10.7326/0003-4819-144-10-200605160-00009 ID - Woo2006 ER - TY - JOUR AU - Khosla, S. PY - 2007 DA - 2007// TI - Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research JO - J Bone Miner Res VL - 22 UR - https://doi.org/10.1359/jbmr.0707onj DO - 10.1359/jbmr.0707onj ID - Khosla2007 ER - TY - JOUR AU - Rugani, P. PY - 2014 DA - 2014// TI - Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer JO - Clin Oral Investig VL - 18 UR - https://doi.org/10.1007/s00784-013-1012-5 DO - 10.1007/s00784-013-1012-5 ID - Rugani2014 ER - TY - JOUR AU - Reid, I. R. AU - Cornish, J. PY - 2012 DA - 2012// TI - Epidemiology and pathogenesis of osteonecrosis of the jaw JO - Nat Rev Rheumatol VL - 8 UR - https://doi.org/10.1038/nrrheum.2011.181 DO - 10.1038/nrrheum.2011.181 ID - Reid2012 ER - TY - JOUR AU - Ruggiero, S. L. PY - 2014 DA - 2014// TI - American Association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw—2014 update JO - J Oral Maxillofac Surg VL - 72 UR - https://doi.org/10.1016/j.joms.2014.04.031 DO - 10.1016/j.joms.2014.04.031 ID - Ruggiero2014 ER - TY - JOUR AU - Kim, J. H. PY - 2015 DA - 2015// TI - Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0118084 DO - 10.1371/journal.pone.0118084 ID - Kim2015 ER - TY - JOUR AU - Sarasquete, M. E. PY - 2008 DA - 2008// TI - Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis JO - Blood VL - 112 UR - https://doi.org/10.1182/blood-2008-04-147884 DO - 10.1182/blood-2008-04-147884 ID - Sarasquete2008 ER - TY - JOUR AU - Choi, H. AU - Lee, J. AU - Lee, J. -. H. AU - Kim, J. -. H. PY - 2015 DA - 2015// TI - Genetic association between VEGF polymorphisms and BRONJ in the Korean population JO - Oral Dis VL - 21 UR - https://doi.org/10.1111/odi.12355 DO - 10.1111/odi.12355 ID - Choi2015 ER - TY - JOUR AU - Arduino, P. G. PY - 2011 DA - 2011// TI - Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws JO - J Oral Pathol Med VL - 40 UR - https://doi.org/10.1111/j.1600-0714.2010.01004.x DO - 10.1111/j.1600-0714.2010.01004.x ID - Arduino2011 ER - TY - JOUR AU - Balla, B. PY - 2012 DA - 2012// TI - New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw JO - Oral Dis VL - 18 UR - https://doi.org/10.1111/j.1601-0825.2012.01912.x DO - 10.1111/j.1601-0825.2012.01912.x ID - Balla2012 ER - TY - JOUR AU - Katz, J. PY - 2011 DA - 2011// TI - Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw JO - Int J Oral Maxillofac Surg VL - 40 UR - https://doi.org/10.1016/j.ijom.2011.02.002 DO - 10.1016/j.ijom.2011.02.002 ID - Katz2011 ER - TY - JOUR AU - Martino, M. T. PY - 2011 DA - 2011// TI - A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling JO - Br J Haematol VL - 154 UR - https://doi.org/10.1111/j.1365-2141.2011.08622.x DO - 10.1111/j.1365-2141.2011.08622.x ID - Martino2011 ER - TY - JOUR AU - Yang, G. PY - 2019 DA - 2019// TI - Pharmacogenomics of osteonecrosis of the jaw JO - Bone VL - 124 UR - https://doi.org/10.1016/j.bone.2019.04.010 DO - 10.1016/j.bone.2019.04.010 ID - Yang2019 ER - TY - JOUR AU - Marini, F. PY - 2011 DA - 2011// TI - Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw JO - Front Biosci (Elite Ed) VL - 3 ID - Marini2011 ER - TY - JOUR AU - Yang, G. PY - 2018 DA - 2018// TI - SIRT1/HERC4 locus associated with bisphosphonate-induced osteonecrosis of the jaw: an exome-wide association analysis JO - J Bone Miner Res VL - 33 UR - https://doi.org/10.1002/jbmr.3285 DO - 10.1002/jbmr.3285 ID - Yang2018 ER - TY - JOUR AU - Lee, K. H. AU - Min, B. J. AU - Kim, J. H. PY - 2019 DA - 2019// TI - Personal genome testing on physicians improves attitudes on pharmacogenomic approaches JO - PLoS ONE VL - 14 UR - https://doi.org/10.1371/journal.pone.0213860 DO - 10.1371/journal.pone.0213860 ID - Lee2019 ER - TY - JOUR AU - Khan, A. A. AU - Rios, L. P. AU - Sandor, G. K. AU - Khan, N. AU - Peters, E. AU - Rahman, M. O. PY - 2011 DA - 2011// TI - Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons JO - J Rheumatol VL - 38 UR - https://doi.org/10.3899/jrheum.100221 DO - 10.3899/jrheum.100221 ID - Khan2011 ER - TY - JOUR AU - Assael, L. A. PY - 2009 DA - 2009// TI - Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies JO - J Oral Maxillofac Surg VL - 67 UR - https://doi.org/10.1016/j.joms.2009.01.003 DO - 10.1016/j.joms.2009.01.003 ID - Assael2009 ER - TY - JOUR AU - Cingolani, P. PY - 2012 DA - 2012// TI - Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program, SnpSift JO - Front Genet VL - 15 ID - Cingolani2012 ER - TY - JOUR AU - Ng, P. a. u. l. i. n. e. C. AU - Henikoff, S. t. e. v. e. n. PY - 2003 DA - 2003// TI - SIFT: predicting amino acid changes that affect protein function JO - Nucleic Acids Res VL - 31 UR - https://doi.org/10.1093/nar/gkg509 DO - 10.1093/nar/gkg509 ID - Ng2003 ER - TY - JOUR AU - Rentzsch, P. PY - 2018 DA - 2018// TI - CADD: predicting the deleteriousness of variants throughout the human genome JO - Nucleic Acids Res VL - 47 UR - https://doi.org/10.1093/nar/gky1016 DO - 10.1093/nar/gky1016 ID - Rentzsch2018 ER - TY - JOUR AU - Lee, K. H. PY - 2016 DA - 2016// TI - Genome sequence variability predicts drug precautions and withdrawals from the market JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0162135 DO - 10.1371/journal.pone.0162135 ID - Lee2016 ER - TY - JOUR AU - Seo, H. PY - 2018 DA - 2018// TI - Deleterious genetic variants in ciliopathy genes increase risk of ritodrine-induced cardiac and pulmonary side effects JO - BMC Med Genomics VL - 11 UR - https://doi.org/10.1186/s12920-018-0323-4 DO - 10.1186/s12920-018-0323-4 ID - Seo2018 ER - TY - JOUR AU - Wu, M. C. PY - 2011 DA - 2011// TI - Rare-variant association testing for sequencing data with the sequence kernel association test JO - Am J Hum Genet VL - 89 UR - https://doi.org/10.1016/j.ajhg.2011.05.029 DO - 10.1016/j.ajhg.2011.05.029 ID - Wu2011 ER - TY - JOUR AU - Auton, A. AU - Brooks, L. D. PY - 2015 DA - 2015// TI - A global reference for human genetic variation JO - Nature VL - 526 UR - https://doi.org/10.1038/nature15393 DO - 10.1038/nature15393 ID - Auton2015 ER - TY - JOUR AU - Lek, M. AU - Karczewski, K. J. AU - Minikel, E. V. AU - Samocha, K. E. AU - Banks, E. AU - Fennell, T. PY - 2015 DA - 2015// TI - Analysis of protein-coding genetic variation in 60,706 humans JO - Nature VL - 30 ID - Lek2015 ER - TY - STD TI - R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. https://www.R-project.org/. UR - https://www.R-project.org/ ID - ref30 ER - TY - JOUR AU - Huang, D. W. PY - 2007 DA - 2007// TI - The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists JO - Genome Biol VL - 8 UR - https://doi.org/10.1186/gb-2007-8-9-r183 DO - 10.1186/gb-2007-8-9-r183 ID - Huang2007 ER - TY - JOUR AU - Strickland, L. A. AU - Jubb, A. M. AU - Hongo, J. A. AU - Zhong, F. AU - Burwick, J. AU - Fu, L. AU - Frantz, G. D. AU - Koeppen, H. PY - 2005 DA - 2005// TI - Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF) JO - J Pathol VL - 206 UR - https://doi.org/10.1002/path.1805 DO - 10.1002/path.1805 ID - Strickland2005 ER - TY - JOUR AU - Nicoletti, P. PY - 2012 DA - 2012// TI - Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3 JO - Oncologist VL - 17 UR - https://doi.org/10.1634/theoncologist.2011-0202 DO - 10.1634/theoncologist.2011-0202 ID - Nicoletti2012 ER - TY - JOUR AU - Stockmann, P. PY - 2013 DA - 2013// TI - Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw JO - J Craniomaxillofac Surg VL - 41 UR - https://doi.org/10.1016/j.jcms.2012.10.018 DO - 10.1016/j.jcms.2012.10.018 ID - Stockmann2013 ER - TY - JOUR AU - English, B. C. PY - 2010 DA - 2010// TI - A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer JO - Ther Clin Risk Manag VL - 6 ID - English2010 ER - TY - JOUR AU - Kastritis, E. PY - 2017 DA - 2017// TI - Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy JO - Leuk Lymphoma VL - 58 UR - https://doi.org/10.1080/10428194.2017.1300889 DO - 10.1080/10428194.2017.1300889 ID - Kastritis2017 ER - TY - JOUR AU - Ferla, F. PY - 2012 DA - 2012// TI - An aromatase polymorphism (g.132810C > T) predicts risk of bisphosphonate-related osteonecrosis of the jaw JO - Biomark Med VL - 6 UR - https://doi.org/10.2217/bmm.12.14 DO - 10.2217/bmm.12.14 ID - Ferla2012 ER - TY - JOUR AU - Such, E. PY - 2011 DA - 2011// TI - CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma JO - Haematologica VL - 96 UR - https://doi.org/10.3324/haematol.2011.042572 DO - 10.3324/haematol.2011.042572 ID - Such2011 ER - TY - JOUR AU - Tetsuro, I. k. e. b. e. PY - 2013 DA - 2013// TI - Pathophysiology of BRONJ: drug-related osteoclastic disease of the jaw JO - Oral Sci Int VL - 10 UR - https://doi.org/10.1016/S1348-8643(12)00045-6 DO - 10.1016/S1348-8643(12)00045-6 ID - Tetsuro2013 ER - TY - JOUR AU - Russell PY - 1999 DA - 1999// TI - Bisphosphonates: pharmacology, mechanisms of action and clinical uses JO - Osteoporos Int VL - 9 UR - https://doi.org/10.1007/PL00004164 DO - 10.1007/PL00004164 ID - Russell1999 ER - TY - JOUR AU - Keyt, B. A. PY - 1996 DA - 1996// TI - The carboxyl-terminal domain (111165) of vascular endothelial growth factor is critical for its mitogenic potency JO - J Biol Chem VL - 271 UR - https://doi.org/10.1074/jbc.271.13.7788 DO - 10.1074/jbc.271.13.7788 ID - Keyt1996 ER - TY - JOUR AU - Bateman, A. AU - Martin, M. J. AU - O’Donovan, C. AU - Magrane, M. AU - Alpi, E. AU - Antunes, R. PY - 2017 DA - 2017// TI - UniProt: the universal protein knowledgebase JO - Nucleic Acids Res VL - 45 UR - https://doi.org/10.1093/nar/gkw1099 DO - 10.1093/nar/gkw1099 ID - Bateman2017 ER - TY - JOUR AU - Philip, A. AU - Bostedt, L. AU - Stigbrand, T. AU - O’Connor‐Mccourt, M. D. PY - 1994 DA - 1994// TI - Binding of transforming growth factor-β (TGF-β) to pregnancy zone protein (PZP) JO - Eur J Biochem VL - 221 UR - https://doi.org/10.1111/j.1432-1033.1994.tb18781.x DO - 10.1111/j.1432-1033.1994.tb18781.x ID - Philip1994 ER - TY - JOUR AU - Pfeilschifter, J. AU - Seyedin, S. M. AU - Mundy, G. R. PY - 1998 DA - 1998// TI - Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures JO - J Clin Invest VL - 82 UR - https://doi.org/10.1172/JCI113647 DO - 10.1172/JCI113647 ID - Pfeilschifter1998 ER - TY - STD TI - Åström P. Regulatory mechanisms mediating matrix metalloproteinase-8 effects in oral tissue repair and tongue cancer. University of Oulu. 2014. ID - ref45 ER - TY - JOUR AU - Immenschuh, S. AU - Vijayan, V. AU - Janciauskiene, S. AU - Gueler, F. PY - 2017 DA - 2017// TI - Heme as a target for therapeutic interventions JO - Front Pharmacol VL - 8 UR - https://doi.org/10.3389/fphar.2017.00146 DO - 10.3389/fphar.2017.00146 ID - Immenschuh2017 ER -